News & Blog
News & Blog
Meet The Community: Belén Martín Avilés
Meet The Community: Erin O’Neil
Meet The Community: Devran Sürmelioğlu
Meet The Community: Rebecca Parisi
Meet The Community: Jessica Hawley
Design Therapeutics Completes Dosing in First Patient Cohort of Phase 1 Trial of DT-216 GeneTAC™ Molecule for the Treatment of Friedreich Ataxia
Meet The Community: Jakub
Meet The Community: Morgan Talevich
Stealth BioTherapeutics Receives Orphan Drug Designation from FDA for Elamipretide for the Treatment of Friedreich’s Ataxia
Meet The Community: Fatbardha Nuzi
